We Appreciate Your Support
Our team is driven by a singular mission: to make radiopharmaceutical imaging and treatment accessible and affordable as soon as possible. And we’re grateful you’re here with us.
Every day our team pushes the limits of what’s possible because we believe in the power of Theranostics and its potential to save lives. It’s going to be a fun ride, and we look forward to sharing it with you.
Check out our latest articles
Prostate Cancer Patients Now Have an Option Other Than Chemotherapy
Prostate cancer patients whose cancer has spread have a game-changing new option for treatment.
May 12, 2025
BAMF Health Doses First Patient in the U.S. in Phase 2b Imaging Study of Brain Metastasis
BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.
April 28, 2025
BAMF Health seeks breast cancer patients for groundbreaking imaging study
This non-invasive clinical trial aims to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.
April 24, 2025